These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 19924564)

  • 1. Psychological aspects of patients with Fabry disease.
    Crosbie TW; Packman W; Packman S
    J Inherit Metab Dis; 2009 Dec; 32(6):745-753. PubMed ID: 19924564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of psychological personality traits in transgender groups using the Minnesota multiphasic personality inventory.
    Liu Y; Wang Z; Dong H; Zhang Y; Yang K; Yang Q; Wang Z; Niu Y
    Front Psychol; 2024; 15():1416011. PubMed ID: 38933582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HomeCageScan analysis reveals ongoing pain in Fabry rats.
    Burand AJ; Waltz TB; Manis AD; Hodges MR; Stucky CL
    Neurobiol Pain; 2023; 13():100113. PubMed ID: 36660199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychiatric symptoms and brain structural alterations in Fabry disease.
    Schermuly I; Müller MJ; Müller KM; Albrecht J; Keller I; Yakushev I; Beck M; Fellgiebel A
    Eur J Neurol; 2011 Feb; 18(2):347-353. PubMed ID: 20636371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat: a modified Delphi study.
    Bichet DG; Hopkin RJ; Aguiar P; Allam SR; Chien YH; Giugliani R; Kallish S; Kineen S; Lidove O; Niu DM; Olivotto I; Politei J; Rakoski P; Torra R; Tøndel C; Hughes DA
    Front Med (Lausanne); 2023; 10():1220637. PubMed ID: 37727761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabry Disease and Central Nervous System Involvement: From Big to Small, from Brain to Synapse.
    Cortés-Saladelafont E; Fernández-Martín J; Ortolano S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared decision making between patients with Fabry disease and physicians in Japan: An online survey.
    Inagaki N; Tsuchiya M; Otani K; Nakayama T
    Mol Genet Metab Rep; 2022 Sep; 32():100899. PubMed ID: 36046392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential consequences of bidirectional promoter methylation on
    Al-Obaide MA; Al-Obaidi II; Vasylyeva TL
    Biomed Rep; 2022 Aug; 17(2):71. PubMed ID: 35910704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexplored regulatory sequences of divergently paired
    Al-Obaide MAI; Al-Obaidi II; Vasylyeva TL
    Exp Ther Med; 2021 Feb; 21(2):154. PubMed ID: 33456521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabry disease: GLA deletion alters a canonical splice site in a family with neuropsychiatric manifestations.
    Varela P; Carvalho G; Martin RP; Pesquero JB
    Metab Brain Dis; 2021 Feb; 36(2):265-272. PubMed ID: 33156427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms in Fabry disease: the importance of coping, subjective health perception and pain.
    Körver S; Geurtsen GJ; Hollak CEM; van Schaik IN; Longo MGF; Lima MR; Vedolin L; Dijkgraaf MGW; Langeveld M
    Orphanet J Rare Dis; 2020 Jan; 15(1):28. PubMed ID: 31992347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment needs and expectations for Fabry disease in France: development of a new Patient Needs Questionnaire.
    Noël E; Dussol B; Lacombe D; Bedreddine N; Fouilhoux A; Ronco P; Genevaz D; Bekri S; Hagège A; Dupuis-Siméon F; Derrien Ansquer V; Germain DP; Lidove O
    Orphanet J Rare Dis; 2019 Dec; 14(1):284. PubMed ID: 31801581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain threshold reflects psychological traits in patients with chronic pain: a cross-sectional study.
    Kato F; Abe T; Kanbara K; Ban I; Kiba T; Kawashima S; Saka Y; Mizuno Y; Fukunaga M
    Biopsychosoc Med; 2017; 11():13. PubMed ID: 28507594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Depression in Adults with Fabry Disease.
    Ali N; Gillespie S; Laney D
    JIMD Rep; 2018; 38():13-21. PubMed ID: 28417336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Enzyme and Substrate Reduction Therapy with a Novel Antagonist of Glucosylceramide Synthase for Fabry Disease.
    Ashe KM; Budman E; Bangari DS; Siegel CS; Nietupski JB; Wang B; Desnick RJ; Scheule RK; Leonard JP; Cheng SH; Marshall J
    Mol Med; 2015 Apr; 21(1):389-99. PubMed ID: 25938659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological health in adults with morquio syndrome.
    Ali N; Cagle S
    JIMD Rep; 2015; 20():87-93. PubMed ID: 25614312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and psychological functioning in Fabry disease.
    Sigmundsdottir L; Tchan MC; Knopman AA; Menzies GC; Batchelor J; Sillence DO
    Arch Clin Neuropsychol; 2014 Nov; 29(7):642-50. PubMed ID: 25319043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive dysfunction and depression in Fabry disease: a systematic review.
    Bolsover FE; Murphy E; Cipolotti L; Werring DJ; Lachmann RH
    J Inherit Metab Dis; 2014 Mar; 37(2):177-87. PubMed ID: 23949010
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.